What is the relative risk of urologic malignancy in microscopic hematuria patients after negative evaluation? A long-term population-based retrospective analysis of 8465 patients
- 2 January 2023
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (3) , 1-9
Abstract
Objective To evaluate whether microscopic hematuria (MH) patients with a negative initial evaluation have an elevated risk for urinary carcinoma. Methods This is a population-based retrospective study with a matched control identified 8465 adults with an MH ICD code, an initial negative urinary malignancy work-up of cystoscopy and CT urography, and at least 35 months of clinical care. 8465 hematuria naïve controls were age, gender, and smoking status matched. Subsequent coding of non-prostatic urinary cancer, or any following hematuria codes: additional microscopic unspecified or unspecified hematuria, and gross hematuria was obtained. Χ2 tests were performed. Results There was no statistically significant difference in urinary malignancy rates (p > 0.05). Any urinary cancer: cases 0.74% (63/8465; 95% CI 0.58–0.95%)/controls 0.83% (71/8465; 95% CI 0.66–1.04%%) (p = 0.54); bladder: 0.45%/0.47% (p = 0.82); renal: 0.31%/0.38% (p = 0.43); ureteral: 0.01%/0.02% (p = 0.56). Subsequent gross hematuria in both males and females increased the odds of cancer: males 2.35 (p = 0.001; CI 1.42–3.91); females 4.25 (p < 0.001; CI 1.94–9.34). Males without additional hematuria had decreased odds ratio: 0.32 (p = 0.001; CI 0.16–0.64). Females without additional hematuria 0.58 (p = 0.19; CI 0.26–1.30) and both genders with additional unspecified hematuria/microscopic hematuria males 1.02 (p = 0.97; CI 0.50–2.08) and females 1.00 (p = 0.99; CI 0.38–2.66) did not have increased odds ratios (p > 0.05). Conclusion MH patients with initial negative evaluation have a subsequent urologic malignancy rate of less than 1% and likely do not need further urinary evaluation unless they develop gross hematuria. Graphical abstractKeywords
This publication has 17 references indexed in Scilit:
- The need for repeated urological evaluation in low-risk patients with microscopic hematuria after negative diagnostic work-up.2013
- Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA GuidelineJournal of Urology, 2012
- Patient‐specific risk of undetected malignant disease after investigation for haematuria, based on a 4‐year follow‐upBJU International, 2010
- Long-term Outcome of Patients With a Negative Work-up for Asymptomatic MicrohematuriaUrology, 2010
- Diagnosis of Urologic Malignancies in Patients with Asymptomatic Dipstick Hematuria: Prospective Study with 13 Years’ Follow-upUrology, 2008
- A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol‐driven haematuria clinicBJU International, 2006
- A new diagnostic algorithm for the evaluation of microscopic hematuriaUrology, 2001
- Urinary tract cancer screening through analysis of urinary red blood cell volume distributionInternational Journal of Urology, 2000
- A PROSPECTIVE ANALYSIS OF 1,930 PATIENTS WITH HEMATURIA TO EVALUATE CURRENT DIAGNOSTIC PRACTICEJournal of Urology, 2000
- Management of microscopic hematuria: Twenty-year experience with 150 cases in a community hospitalUrology, 1986